vs
Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($76.4M vs $27.6M, roughly 2.8× Beta Bionics, Inc.). PROCEPT BioRobotics Corp runs the higher net margin — -39.1% vs -79.3%, a 40.2% gap on every dollar of revenue. On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs 11.9%).
Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
BBNX vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $76.4M |
| Net Profit | $-21.9M | $-29.8M |
| Gross Margin | 59.5% | 60.6% |
| Operating Margin | — | -40.6% |
| Net Margin | -79.3% | -39.1% |
| Revenue YoY | 56.6% | 11.9% |
| Net Profit YoY | 23.6% | -58.3% |
| EPS (diluted) | $-0.49 | $-0.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $27.6M | — | ||
| Q4 25 | $32.1M | $76.4M | ||
| Q3 25 | $27.3M | $83.3M | ||
| Q2 25 | $23.2M | $79.2M | ||
| Q1 25 | $17.6M | $69.2M | ||
| Q4 24 | — | $68.2M | ||
| Q3 24 | — | $58.4M | ||
| Q2 24 | — | $53.4M |
| Q1 26 | $-21.9M | — | ||
| Q4 25 | $-13.5M | $-29.8M | ||
| Q3 25 | $-14.2M | $-21.4M | ||
| Q2 25 | $-16.9M | $-19.6M | ||
| Q1 25 | $-28.7M | $-24.7M | ||
| Q4 24 | — | $-18.9M | ||
| Q3 24 | — | $-21.0M | ||
| Q2 24 | — | $-25.6M |
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.0% | 60.6% | ||
| Q3 25 | 55.5% | 64.8% | ||
| Q2 25 | 53.8% | 65.4% | ||
| Q1 25 | 50.9% | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | — | ||
| Q4 25 | -50.2% | -40.6% | ||
| Q3 25 | -62.5% | -27.8% | ||
| Q2 25 | -85.5% | -28.0% | ||
| Q1 25 | -105.7% | -39.7% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | — | -38.4% | ||
| Q2 24 | — | -50.3% |
| Q1 26 | -79.3% | — | ||
| Q4 25 | -41.9% | -39.1% | ||
| Q3 25 | -52.1% | -25.7% | ||
| Q2 25 | -72.6% | -24.7% | ||
| Q1 25 | -162.5% | -35.8% | ||
| Q4 24 | — | -27.6% | ||
| Q3 24 | — | -35.9% | ||
| Q2 24 | — | -48.0% |
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-0.16 | $-0.54 | ||
| Q3 25 | $-0.33 | $-0.38 | ||
| Q2 25 | $-0.39 | $-0.35 | ||
| Q1 25 | $-0.93 | $-0.45 | ||
| Q4 24 | — | $-0.34 | ||
| Q3 24 | — | $-0.40 | ||
| Q2 24 | — | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $199.5M | $286.5M |
| Total DebtLower is stronger | — | $51.6M |
| Stockholders' EquityBook value | $271.2M | $365.9M |
| Total Assets | $304.4M | $508.1M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $199.5M | — | ||
| Q4 25 | $219.1M | $286.5M | ||
| Q3 25 | $228.7M | $294.3M | ||
| Q2 25 | $249.7M | $302.7M | ||
| Q1 25 | $231.5M | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | $271.2M | — | ||
| Q4 25 | $287.6M | $365.9M | ||
| Q3 25 | $294.8M | $380.3M | ||
| Q2 25 | $301.6M | $385.8M | ||
| Q1 25 | $313.8M | $389.2M | ||
| Q4 24 | — | $402.2M | ||
| Q3 24 | — | $241.2M | ||
| Q2 24 | — | $251.8M |
| Q1 26 | $304.4M | — | ||
| Q4 25 | $328.7M | $508.1M | ||
| Q3 25 | $330.0M | $511.5M | ||
| Q2 25 | $330.0M | $513.1M | ||
| Q1 25 | $338.0M | $519.4M | ||
| Q4 24 | — | $534.0M | ||
| Q3 24 | — | $374.1M | ||
| Q2 24 | — | $374.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-10.3M |
| Free Cash FlowOCF − Capex | — | $-12.2M |
| FCF MarginFCF / Revenue | — | -15.9% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-8.6M | $-10.3M | ||
| Q3 25 | $-8.7M | $-6.6M | ||
| Q2 25 | $-13.6M | $-15.0M | ||
| Q1 25 | $-20.0M | $-17.0M | ||
| Q4 24 | — | $-32.4M | ||
| Q3 24 | — | $-18.8M | ||
| Q2 24 | — | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-10.5M | $-12.2M | ||
| Q3 25 | $-10.0M | $-9.5M | ||
| Q2 25 | $-15.4M | $-17.8M | ||
| Q1 25 | $-20.3M | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | -32.8% | -15.9% | ||
| Q3 25 | -36.7% | -11.4% | ||
| Q2 25 | -66.2% | -22.5% | ||
| Q1 25 | -115.1% | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | 2.4% | ||
| Q3 25 | 4.7% | 3.4% | ||
| Q2 25 | 7.7% | 3.5% | ||
| Q1 25 | 1.9% | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBNX
Segment breakdown not available.
PRCT
| Hand Pieces And Other Consumables | $34.1M | 45% |
| System Sales And Rentals | $27.5M | 36% |
| Other | $9.8M | 13% |
| Service Revenue | $5.0M | 7% |
